GFM
PRME icon

GF Fund Management’s Prime Medicine PRME Stock Holding History

GF Fund Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14K Buy
4,036
+489
+14% +$1.86K ﹤0.01% 530
2025
Q4 		$12.3K Sell
3,547
-215
-6% -$956 ﹤0.01% 560
2025
Q3 		$20.8K Buy
3,762
+404
+12% +$1.64K ﹤0.01% 484
2025
Q2 		$8.29K Hold
3,358
– – ﹤0.01% 588
2025
Q1 		$6.68K Buy
3,358
+658
+24% +$1.68K ﹤0.01% 604
2024
Q4 		$7.88K Buy
+2,700
New +$9.48K ﹤0.01% 576

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

GF Fund Management's PRME Position: Q1 2026 in Review

GF Fund Management increased its Prime Medicine (PRME) stake by 14% in Q1 2026, buying an estimated $1.86K and bringing the position to 4,036 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #530.

GF Fund Management first reported a position in PRME in Q4 2024 and has held it in 6 quarters since. The position peaked at $20.8K in Q3 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • GF Fund Management held 4,036 shares of Prime Medicine worth $14K as of Q1 2026.
  • GF Fund Management bought 489 Prime Medicine shares in Q1 2026, an estimated $1.86K.
  • Prime Medicine made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #530 holding.
  • GF Fund Management first reported a position in Prime Medicine in Q4 2024 and has held it in 6 quarters since.
  • GF Fund Management's Prime Medicine position peaked at $20.8K in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.